Promising in vitro Anti-Toxoplasma gondii effects of commercial Chitosan.

CONCLUSION: Our results indicate chitosan in low molecular weight had potent activity against T. gondii tachyzoites and could be an appropriate candidate for treatment of at least acute toxoplasmosis, certainly, after complementary in vivo experiments.
PMID: 32389115 [PubMed - as supplied by publisher]

Source: Infectious Disorders Drug Targets - May 9, 2020 Category: Infectious Diseases Authors: Esboei BR, Keighobadi M, Hezarjaribi HZ, Fakhar M, Daryani A, Chabra A, Soosaraei M, Yalveh R Tags: Infect Disord Drug Targets Source Type: research